BMC Public Health · 2019 · 97 citations · 53 references
Public HealthPreventive MedicinePsychiatryBehavioral HealthHiv PreventionVictimologyHiv EpidemiologyIntimate Partner Violence PreventionPre-exposure ProphylaxisSexual HealthSexual Health PreventionSexual Violence PreventionGay Men's HealthHiv Behavioral EpidemiologyPre-exposure Prophylaxis Among Serodiscordant CouplesPre-exposure Prophylaxis ComparisonPre-exposure Prophylaxis EpidemiologyPre-exposure Prophylaxis ImplementationPsychosocial FunctioningVictimization In Same-sex Relationships
BACKGROUND: Little is known about the prevalence and correlates of intimate partner violence (IPV) among gay, bisexual and other men who have sex with men (GBMSM) in the UK. The aim of this study was to investigate the prevalence of IPV, associations of socio-economic and psychosocial factors with IPV, and the association of IPV with depression and sexual behaviour, among GBMSM in the PROUD trial of pre-exposure prophylaxis (PrEP). METHODS: PROUD enrolled 544 HIV-negative participants in England from 2012 to 2014; participants were randomised to immediate or deferred PrEP. This analysis included 436 GBMSM who had IPV data at month-12 and/or 24. Prevalence of IPV victimization and perpetration (lifetime, and in the past year) was assessed at these time-points. Generalized estimating equations were used to investigate associations with IPV, using pooled data from both time-points. RESULTS: At month-12 (N = 410), 44.9% of men reported ever being a victim of IPV, 15.6% in the last year, and 19.5% reported ever perpetrating IPV, 7.8% in the last year. At month-24 (N = 333), the corresponding prevalence was 40.2 and 14.7% for lifetime and past year IPV victimization and 18.0 and 6.9% for lifetime and past year IPV perpetration. IPV prevalence did not differ by randomised arm. Men reporting internalized homophobia and sexualized drug use were more likely to report IPV. Lifetime and last year experience of IPV victimization and perpetration were strongly associated with depressive symptoms (PHQ-9 ≥ 10) (adjusted for socio-demographics: lifetime IPV victimization PR 2.57 [95% CI: 1.71, 3.86]; past year IPV victimization PR 2.93 [95% CI: 1.96, 4.40]; lifetime IPV perpetration PR 2.87 [95% CI: 1.91, 4.32]; past year IPV perpetration PR 3.47 [95% CI: 2.13, 5.64], p < 0.001 for all); IPV was not consistently associated with measures of condomless anal sex or high partner numbers. CONCLUSIONS: GBMSM at high-risk of HIV who are seeking/taking PrEP may experience a high burden of IPV, which may be linked to depression. Training on awareness of and enquiry for IPV among GBMSM in sexual health clinics is recommended. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02065986 . Registered 19 February 2014 (retrospectively registered).
53
Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams · Journal of General Internal Medicine · 2001 · 44.2K citations · Full text
Raewyn Connell, James W. Messerschmidt · Gender & Society · 2005 · 8.9K citations · Full text
Sheena McCormack, David Dunn, Monica Desai et al. · The Lancet · 2015 · 1.9K citations · Full text